nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Omeprazole—Barrett's esophagus	0.413	0.735	CbGbCtD
Afatinib—ABCB1—Omeprazole—Barrett's esophagus	0.149	0.265	CbGbCtD
Afatinib—ERBB2—exocrine gland—Barrett's esophagus	0.0197	0.299	CbGeAlD
Afatinib—ERBB2—epithelium—Barrett's esophagus	0.00858	0.13	CbGeAlD
Afatinib—ERBB4—epithelium—Barrett's esophagus	0.00858	0.13	CbGeAlD
Afatinib—ERBB2—smooth muscle tissue—Barrett's esophagus	0.00826	0.125	CbGeAlD
Afatinib—ERBB2—digestive system—Barrett's esophagus	0.00653	0.0989	CbGeAlD
Afatinib—IRAK1—smooth muscle tissue—Barrett's esophagus	0.00618	0.0937	CbGeAlD
Afatinib—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00501	0.0196	CcSEcCtD
Afatinib—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00501	0.0196	CcSEcCtD
Afatinib—Cystitis—Esomeprazole—Barrett's esophagus	0.00495	0.0194	CcSEcCtD
Afatinib—Cystitis—Omeprazole—Barrett's esophagus	0.00495	0.0194	CcSEcCtD
Afatinib—Dry eye—Omeprazole—Barrett's esophagus	0.00473	0.0185	CcSEcCtD
Afatinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00473	0.0185	CcSEcCtD
Afatinib—Bladder pain—Esomeprazole—Barrett's esophagus	0.00463	0.0181	CcSEcCtD
Afatinib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00463	0.0181	CcSEcCtD
Afatinib—Bladder pain—Omeprazole—Barrett's esophagus	0.00463	0.0181	CcSEcCtD
Afatinib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00463	0.0181	CcSEcCtD
Afatinib—Renal impairment—Omeprazole—Barrett's esophagus	0.00391	0.0153	CcSEcCtD
Afatinib—Renal impairment—Esomeprazole—Barrett's esophagus	0.00391	0.0153	CcSEcCtD
Afatinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00346	0.0525	CbGeAlD
Afatinib—Dry skin—Esomeprazole—Barrett's esophagus	0.00341	0.0133	CcSEcCtD
Afatinib—Dry skin—Omeprazole—Barrett's esophagus	0.00341	0.0133	CcSEcCtD
Afatinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00339	0.0133	CcSEcCtD
Afatinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00339	0.0133	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00335	0.0131	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00335	0.0131	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00328	0.0128	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00328	0.0128	CcSEcCtD
Afatinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00299	0.0117	CcSEcCtD
Afatinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00299	0.0117	CcSEcCtD
Afatinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00291	0.0114	CcSEcCtD
Afatinib—Weight decreased—Omeprazole—Barrett's esophagus	0.00291	0.0114	CcSEcCtD
Afatinib—Infestation—Omeprazole—Barrett's esophagus	0.00287	0.0112	CcSEcCtD
Afatinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00287	0.0112	CcSEcCtD
Afatinib—Infestation—Esomeprazole—Barrett's esophagus	0.00287	0.0112	CcSEcCtD
Afatinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00287	0.0112	CcSEcCtD
Afatinib—Renal failure—Esomeprazole—Barrett's esophagus	0.00282	0.011	CcSEcCtD
Afatinib—Renal failure—Omeprazole—Barrett's esophagus	0.00282	0.011	CcSEcCtD
Afatinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—Stomatitis—Omeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00279	0.0109	CcSEcCtD
Afatinib—ABL1—digestive system—Barrett's esophagus	0.00273	0.0414	CbGeAlD
Afatinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00271	0.0106	CcSEcCtD
Afatinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00271	0.0106	CcSEcCtD
Afatinib—Epistaxis—Omeprazole—Barrett's esophagus	0.0027	0.0106	CcSEcCtD
Afatinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.0027	0.0106	CcSEcCtD
Afatinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00254	0.00995	CcSEcCtD
Afatinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00254	0.00995	CcSEcCtD
Afatinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00253	0.0099	CcSEcCtD
Afatinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00253	0.0099	CcSEcCtD
Afatinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00252	0.00987	CcSEcCtD
Afatinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00252	0.00987	CcSEcCtD
Afatinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00241	0.00941	CcSEcCtD
Afatinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00241	0.00941	CcSEcCtD
Afatinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00232	0.00908	CcSEcCtD
Afatinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00232	0.00908	CcSEcCtD
Afatinib—Alopecia—Omeprazole—Barrett's esophagus	0.00227	0.0089	CcSEcCtD
Afatinib—Alopecia—Esomeprazole—Barrett's esophagus	0.00227	0.0089	CcSEcCtD
Afatinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.00225	0.00882	CcSEcCtD
Afatinib—Mental disorder—Omeprazole—Barrett's esophagus	0.00225	0.00882	CcSEcCtD
Afatinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00224	0.00877	CcSEcCtD
Afatinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00224	0.00877	CcSEcCtD
Afatinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00219	0.00859	CcSEcCtD
Afatinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.00219	0.00859	CcSEcCtD
Afatinib—Back pain—Omeprazole—Barrett's esophagus	0.00217	0.00848	CcSEcCtD
Afatinib—Back pain—Esomeprazole—Barrett's esophagus	0.00217	0.00848	CcSEcCtD
Afatinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00215	0.00843	CcSEcCtD
Afatinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.00215	0.00843	CcSEcCtD
Afatinib—Cough—Omeprazole—Barrett's esophagus	0.00196	0.00765	CcSEcCtD
Afatinib—Cough—Esomeprazole—Barrett's esophagus	0.00196	0.00765	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00189	0.00741	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00189	0.00741	CcSEcCtD
Afatinib—Infection—Omeprazole—Barrett's esophagus	0.00182	0.00711	CcSEcCtD
Afatinib—Infection—Esomeprazole—Barrett's esophagus	0.00182	0.00711	CcSEcCtD
Afatinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00179	0.00702	CcSEcCtD
Afatinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00179	0.00702	CcSEcCtD
Afatinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.00178	0.00695	CcSEcCtD
Afatinib—Skin disorder—Omeprazole—Barrett's esophagus	0.00178	0.00695	CcSEcCtD
Afatinib—Insomnia—Omeprazole—Barrett's esophagus	0.00165	0.00647	CcSEcCtD
Afatinib—Insomnia—Esomeprazole—Barrett's esophagus	0.00165	0.00647	CcSEcCtD
Afatinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.00163	0.00638	CcSEcCtD
Afatinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00163	0.00638	CcSEcCtD
Afatinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.00161	0.0063	CcSEcCtD
Afatinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00161	0.0063	CcSEcCtD
Afatinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.00159	0.00622	CcSEcCtD
Afatinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00159	0.00622	CcSEcCtD
Afatinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00158	0.00618	CcSEcCtD
Afatinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00158	0.00618	CcSEcCtD
Afatinib—Fatigue—Omeprazole—Barrett's esophagus	0.00158	0.00617	CcSEcCtD
Afatinib—Fatigue—Esomeprazole—Barrett's esophagus	0.00158	0.00617	CcSEcCtD
Afatinib—Constipation—Omeprazole—Barrett's esophagus	0.00156	0.00612	CcSEcCtD
Afatinib—Constipation—Esomeprazole—Barrett's esophagus	0.00156	0.00612	CcSEcCtD
Afatinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00145	0.00566	CcSEcCtD
Afatinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.00145	0.00566	CcSEcCtD
Afatinib—Asthenia—Omeprazole—Barrett's esophagus	0.00131	0.00513	CcSEcCtD
Afatinib—Asthenia—Esomeprazole—Barrett's esophagus	0.00131	0.00513	CcSEcCtD
Afatinib—Pruritus—Esomeprazole—Barrett's esophagus	0.00129	0.00506	CcSEcCtD
Afatinib—Pruritus—Omeprazole—Barrett's esophagus	0.00129	0.00506	CcSEcCtD
Afatinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00125	0.0049	CcSEcCtD
Afatinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00125	0.0049	CcSEcCtD
Afatinib—Dizziness—Esomeprazole—Barrett's esophagus	0.00121	0.00473	CcSEcCtD
Afatinib—Dizziness—Omeprazole—Barrett's esophagus	0.00121	0.00473	CcSEcCtD
Afatinib—Vomiting—Omeprazole—Barrett's esophagus	0.00116	0.00455	CcSEcCtD
Afatinib—Vomiting—Esomeprazole—Barrett's esophagus	0.00116	0.00455	CcSEcCtD
Afatinib—Rash—Omeprazole—Barrett's esophagus	0.00115	0.00451	CcSEcCtD
Afatinib—Rash—Esomeprazole—Barrett's esophagus	0.00115	0.00451	CcSEcCtD
Afatinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.00115	0.00451	CcSEcCtD
Afatinib—Dermatitis—Omeprazole—Barrett's esophagus	0.00115	0.00451	CcSEcCtD
Afatinib—Headache—Esomeprazole—Barrett's esophagus	0.00115	0.00448	CcSEcCtD
Afatinib—Headache—Omeprazole—Barrett's esophagus	0.00115	0.00448	CcSEcCtD
Afatinib—ABCB1—epithelium—Barrett's esophagus	0.00112	0.0169	CbGeAlD
Afatinib—Nausea—Omeprazole—Barrett's esophagus	0.00109	0.00425	CcSEcCtD
Afatinib—Nausea—Esomeprazole—Barrett's esophagus	0.00109	0.00425	CcSEcCtD
Afatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—Barrett's esophagus	0.00101	0.0087	CbGpPWpGaD
Afatinib—DYRK1A—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.001	0.0086	CbGpPWpGaD
Afatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000984	0.00846	CbGpPWpGaD
Afatinib—EGFR—Syndecan-3-mediated signaling events—CXCL8—Barrett's esophagus	0.000964	0.00828	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—MCL1—Barrett's esophagus	0.00092	0.00791	CbGpPWpGaD
Afatinib—ABL1—miRNAs involved in DNA damage response—TP53—Barrett's esophagus	0.000906	0.00779	CbGpPWpGaD
Afatinib—ERBB2—Bladder Cancer—TP53—Barrett's esophagus	0.000896	0.0077	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000865	0.00744	CbGpPWpGaD
Afatinib—ABCB1—digestive system—Barrett's esophagus	0.00085	0.0129	CbGeAlD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000848	0.00729	CbGpPWpGaD
Afatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000836	0.00719	CbGpPWpGaD
Afatinib—IRAK1—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000803	0.0069	CbGpPWpGaD
Afatinib—EGFR—Bladder Cancer—CDKN2A—Barrett's esophagus	0.000778	0.00669	CbGpPWpGaD
Afatinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—Barrett's esophagus	0.000764	0.00657	CbGpPWpGaD
Afatinib—ERBB2—Leptin signaling pathway—RELA—Barrett's esophagus	0.000764	0.00657	CbGpPWpGaD
Afatinib—EGFR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000764	0.00656	CbGpPWpGaD
Afatinib—ABL1—TP53 Network—TP53—Barrett's esophagus	0.00075	0.00645	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000739	0.00635	CbGpPWpGaD
Afatinib—ERBB2—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.000725	0.00623	CbGpPWpGaD
Afatinib—IRAK1—Signaling by Interleukins—HGF—Barrett's esophagus	0.000711	0.00611	CbGpPWpGaD
Afatinib—IRAK1—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000708	0.00609	CbGpPWpGaD
Afatinib—EGFR—Bladder Cancer—CXCL8—Barrett's esophagus	0.000706	0.00607	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—PTGES—Barrett's esophagus	0.000672	0.00578	CbGpPWpGaD
Afatinib—BLK—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000645	0.00554	CbGpPWpGaD
Afatinib—LCK—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.000627	0.00539	CbGpPWpGaD
Afatinib—ERBB2—Focal Adhesion—HGF—Barrett's esophagus	0.000626	0.00538	CbGpPWpGaD
Afatinib—BLK—Focal Adhesion—HGF—Barrett's esophagus	0.000593	0.0051	CbGpPWpGaD
Afatinib—ABL1—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.000592	0.00508	CbGpPWpGaD
Afatinib—BLK—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000589	0.00507	CbGpPWpGaD
Afatinib—ERBB2—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000589	0.00506	CbGpPWpGaD
Afatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—Barrett's esophagus	0.000584	0.00502	CbGpPWpGaD
Afatinib—EGFR—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000577	0.00496	CbGpPWpGaD
Afatinib—LCK—Downstream TCR signaling—RELA—Barrett's esophagus	0.000577	0.00496	CbGpPWpGaD
Afatinib—ERBB2—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000575	0.00494	CbGpPWpGaD
Afatinib—ERBB4—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000566	0.00487	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000561	0.00483	CbGpPWpGaD
Afatinib—IRAK1—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000553	0.00475	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000546	0.00469	CbGpPWpGaD
Afatinib—ABL1—p53 pathway—CDKN2A—Barrett's esophagus	0.000544	0.00468	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000531	0.00456	CbGpPWpGaD
Afatinib—LCK—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000517	0.00445	CbGpPWpGaD
Afatinib—IRAK1—p75 NTR receptor-mediated signalling—RELA—Barrett's esophagus	0.000514	0.00442	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CYP26A1—Barrett's esophagus	0.000509	0.00438	CbGpPWpGaD
Afatinib—IRAK1—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.0005	0.0043	CbGpPWpGaD
Afatinib—ABL1—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000498	0.00428	CbGpPWpGaD
Afatinib—IRAK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000495	0.00426	CbGpPWpGaD
Afatinib—IRAK1—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000492	0.00423	CbGpPWpGaD
Afatinib—LCK—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000488	0.00419	CbGpPWpGaD
Afatinib—IRAK1—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000486	0.00418	CbGpPWpGaD
Afatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000484	0.00416	CbGpPWpGaD
Afatinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000469	0.00403	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000463	0.00398	CbGpPWpGaD
Afatinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000461	0.00396	CbGpPWpGaD
Afatinib—LCK—Signaling by Interleukins—HGF—Barrett's esophagus	0.000458	0.00394	CbGpPWpGaD
Afatinib—IRAK1—MyD88-independent cascade—RELA—Barrett's esophagus	0.000442	0.0038	CbGpPWpGaD
Afatinib—PHKG2—Disease—SLC9A1—Barrett's esophagus	0.000438	0.00377	CbGpPWpGaD
Afatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000434	0.00373	CbGpPWpGaD
Afatinib—EGFR—Bladder Cancer—TP53—Barrett's esophagus	0.000433	0.00372	CbGpPWpGaD
Afatinib—EGFR—Gastric Cancer Network 2—TP53—Barrett's esophagus	0.000433	0.00372	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—APC—Barrett's esophagus	0.000433	0.00372	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000432	0.00371	CbGpPWpGaD
Afatinib—LCK—TCR signaling—RELA—Barrett's esophagus	0.000431	0.00371	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000426	0.00366	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—RELA—Barrett's esophagus	0.000419	0.0036	CbGpPWpGaD
Afatinib—ABL1—p73 transcription factor network—RELA—Barrett's esophagus	0.000415	0.00356	CbGpPWpGaD
Afatinib—ABL1—ATM Signaling Pathway—TP53—Barrett's esophagus	0.000413	0.00355	CbGpPWpGaD
Afatinib—IRAK1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000413	0.00355	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000412	0.00354	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.00041	0.00353	CbGpPWpGaD
Afatinib—EGFR—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000409	0.00352	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000407	0.0035	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—TP53—Barrett's esophagus	0.000405	0.00348	CbGpPWpGaD
Afatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000404	0.00348	CbGpPWpGaD
Afatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000403	0.00346	CbGpPWpGaD
Afatinib—IRAK1—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000398	0.00342	CbGpPWpGaD
Afatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000397	0.00341	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000395	0.0034	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—HGF—Barrett's esophagus	0.000386	0.00332	CbGpPWpGaD
Afatinib—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000385	0.00331	CbGpPWpGaD
Afatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000384	0.0033	CbGpPWpGaD
Afatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000379	0.00325	CbGpPWpGaD
Afatinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000374	0.00322	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—SLC9A1—Barrett's esophagus	0.000367	0.00316	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000367	0.00315	CbGpPWpGaD
Afatinib—BLK—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000359	0.00308	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000357	0.00307	CbGpPWpGaD
Afatinib—ERBB2—B Cell Activation—RELA—Barrett's esophagus	0.000356	0.00306	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000352	0.00302	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—CDKN2A—Barrett's esophagus	0.000351	0.00302	CbGpPWpGaD
Afatinib—ERBB4—B Cell Activation—RELA—Barrett's esophagus	0.00035	0.00301	CbGpPWpGaD
Afatinib—IRAK1—p75(NTR)-mediated signaling—TP53—Barrett's esophagus	0.000342	0.00294	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000337	0.0029	CbGpPWpGaD
Afatinib—BLK—B Cell Activation—RELA—Barrett's esophagus	0.000337	0.0029	CbGpPWpGaD
Afatinib—IRAK1—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000333	0.00287	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000333	0.00286	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000332	0.00285	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle—CDKN2A—Barrett's esophagus	0.000328	0.00282	CbGpPWpGaD
Afatinib—ERBB2—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000328	0.00282	CbGpPWpGaD
Afatinib—ABL1—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000325	0.00279	CbGpPWpGaD
Afatinib—EGFR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000322	0.00277	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000318	0.00273	CbGpPWpGaD
Afatinib—ABL1—p53 pathway—TP53—Barrett's esophagus	0.000303	0.0026	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—HGF—Barrett's esophagus	0.000303	0.0026	CbGpPWpGaD
Afatinib—LCK—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00029	0.00249	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—APC—Barrett's esophagus	0.000287	0.00247	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000286	0.00246	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—PPARG—Barrett's esophagus	0.000282	0.00243	CbGpPWpGaD
Afatinib—EGFR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000278	0.00239	CbGpPWpGaD
Afatinib—IRAK1—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000274	0.00235	CbGpPWpGaD
Afatinib—EGFR—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000273	0.00235	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response—TP53—Barrett's esophagus	0.00027	0.00232	CbGpPWpGaD
Afatinib—LCK—Signaling by Interleukins—RELA—Barrett's esophagus	0.000266	0.00229	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000262	0.00225	CbGpPWpGaD
Afatinib—ERBB2—Signaling by NGF—RELA—Barrett's esophagus	0.000262	0.00225	CbGpPWpGaD
Afatinib—ABL1—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	0.000261	0.00225	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000258	0.00222	CbGpPWpGaD
Afatinib—ERBB4—Signaling by NGF—RELA—Barrett's esophagus	0.000258	0.00222	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00025	0.00215	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000242	0.00208	CbGpPWpGaD
Afatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000234	0.00201	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—RELA—Barrett's esophagus	0.000229	0.00196	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000224	0.00192	CbGpPWpGaD
Afatinib—ABL1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000222	0.00191	CbGpPWpGaD
Afatinib—ERBB2—Disease—SLC9A1—Barrett's esophagus	0.000217	0.00187	CbGpPWpGaD
Afatinib—ERBB4—Disease—SLC9A1—Barrett's esophagus	0.000214	0.00184	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000214	0.00184	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000209	0.0018	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—PPARG—Barrett's esophagus	0.000209	0.0018	CbGpPWpGaD
Afatinib—PHKG2—Disease—APC—Barrett's esophagus	0.000207	0.00178	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000199	0.00171	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000199	0.00171	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—GAST—Barrett's esophagus	0.000199	0.00171	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—GAST—Barrett's esophagus	0.000196	0.00168	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—TP53—Barrett's esophagus	0.000196	0.00168	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000195	0.00167	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000193	0.00166	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—RELA—Barrett's esophagus	0.000189	0.00163	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000188	0.00161	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000186	0.0016	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000185	0.00159	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle—TP53—Barrett's esophagus	0.000183	0.00157	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000179	0.00154	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000175	0.00151	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—RELA—Barrett's esophagus	0.000172	0.00148	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.00017	0.00146	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—RELA—Barrett's esophagus	0.000169	0.00145	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000169	0.00145	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—PPARG—Barrett's esophagus	0.000168	0.00144	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—RELA—Barrett's esophagus	0.000166	0.00142	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—GAST—Barrett's esophagus	0.000162	0.0014	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—HGF—Barrett's esophagus	0.000162	0.00139	CbGpPWpGaD
Afatinib—PHKG2—Disease—PTGS2—Barrett's esophagus	0.000157	0.00135	CbGpPWpGaD
Afatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	0.000155	0.00133	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000155	0.00133	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	0.00015	0.00129	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HGF—Barrett's esophagus	0.00015	0.00129	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—RELA—Barrett's esophagus	0.000149	0.00128	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TP53—Barrett's esophagus	0.000149	0.00128	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HGF—Barrett's esophagus	0.000148	0.00127	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—RELA—Barrett's esophagus	0.000147	0.00126	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—GAST—Barrett's esophagus	0.000144	0.00123	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—RELA—Barrett's esophagus	0.000143	0.00123	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000143	0.00123	CbGpPWpGaD
Afatinib—BLK—Immune System—HGF—Barrett's esophagus	0.000142	0.00122	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—RELA—Barrett's esophagus	0.000141	0.00121	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SST—Barrett's esophagus	0.000136	0.00117	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—RELA—Barrett's esophagus	0.000136	0.00117	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SST—Barrett's esophagus	0.000134	0.00115	CbGpPWpGaD
Afatinib—LCK—Hemostasis—HGF—Barrett's esophagus	0.000133	0.00115	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—PTGS2—Barrett's esophagus	0.000132	0.00113	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—TP53—Barrett's esophagus	0.00013	0.00111	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—RELA—Barrett's esophagus	0.000127	0.00109	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000124	0.00107	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000122	0.00105	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	0.000122	0.00105	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000118	0.00102	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	0.000118	0.00102	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	0.000114	0.00098	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000113	0.000971	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000112	0.000963	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—SST—Barrett's esophagus	0.000111	0.000957	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HGF—Barrett's esophagus	0.000108	0.000932	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—RELA—Barrett's esophagus	0.000108	0.000928	CbGpPWpGaD
Afatinib—EGFR—Disease—SLC9A1—Barrett's esophagus	0.000105	0.000903	CbGpPWpGaD
Afatinib—ERBB2—Disease—APC—Barrett's esophagus	0.000103	0.000884	CbGpPWpGaD
Afatinib—ERBB4—Disease—APC—Barrett's esophagus	0.000101	0.00087	CbGpPWpGaD
Afatinib—LCK—Disease—SLC9A1—Barrett's esophagus	0.000101	0.00087	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000101	0.000869	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—PPARG—Barrett's esophagus	0.000101	0.000868	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SST—Barrett's esophagus	9.84e-05	0.000846	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GAST—Barrett's esophagus	9.6e-05	0.000825	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	9.57e-05	0.000822	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.48e-05	0.000815	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	9.25e-05	0.000795	CbGpPWpGaD
Afatinib—ERBB2—Immune System—RELA—Barrett's esophagus	8.7e-05	0.000748	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.58e-05	0.000737	CbGpPWpGaD
Afatinib—ERBB4—Immune System—RELA—Barrett's esophagus	8.57e-05	0.000737	CbGpPWpGaD
Afatinib—ABL1—Immune System—HGF—Barrett's esophagus	8.48e-05	0.000729	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	8.45e-05	0.000726	CbGpPWpGaD
Afatinib—BLK—Immune System—RELA—Barrett's esophagus	8.24e-05	0.000709	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	8.22e-05	0.000706	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—RELA—Barrett's esophagus	8.18e-05	0.000703	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	8.13e-05	0.000699	CbGpPWpGaD
Afatinib—ERBB2—Disease—PTGS2—Barrett's esophagus	7.81e-05	0.000671	CbGpPWpGaD
Afatinib—ERBB4—Disease—PTGS2—Barrett's esophagus	7.69e-05	0.000661	CbGpPWpGaD
Afatinib—EGFR—Immune System—HGF—Barrett's esophagus	7.25e-05	0.000623	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—RELA—Barrett's esophagus	7.22e-05	0.000621	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—APC—Barrett's esophagus	7.2e-05	0.000619	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—APC—Barrett's esophagus	7.09e-05	0.000609	CbGpPWpGaD
Afatinib—LCK—Immune System—HGF—Barrett's esophagus	6.99e-05	0.0006	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—RELA—Barrett's esophagus	6.96e-05	0.000598	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—RELA—Barrett's esophagus	6.94e-05	0.000596	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	6.68e-05	0.000574	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SST—Barrett's esophagus	6.58e-05	0.000565	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SST—Barrett's esophagus	6.34e-05	0.000545	CbGpPWpGaD
Afatinib—IRAK1—Immune System—RELA—Barrett's esophagus	6.29e-05	0.000541	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	6.16e-05	0.00053	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—RELA—Barrett's esophagus	5.63e-05	0.000483	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RELA—Barrett's esophagus	5.54e-05	0.000476	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TP53—Barrett's esophagus	5.43e-05	0.000467	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL8—Barrett's esophagus	5.3e-05	0.000456	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL8—Barrett's esophagus	5.22e-05	0.000449	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—APC—Barrett's esophagus	5.21e-05	0.000447	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.11e-05	0.000439	CbGpPWpGaD
Afatinib—EGFR—Disease—APC—Barrett's esophagus	4.97e-05	0.000427	CbGpPWpGaD
Afatinib—ABL1—Immune System—RELA—Barrett's esophagus	4.92e-05	0.000423	CbGpPWpGaD
Afatinib—LCK—Disease—APC—Barrett's esophagus	4.79e-05	0.000412	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TP53—Barrett's esophagus	4.47e-05	0.000384	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	4.44e-05	0.000382	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	4.34e-05	0.000373	CbGpPWpGaD
Afatinib—EGFR—Immune System—RELA—Barrett's esophagus	4.21e-05	0.000362	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RELA—Barrett's esophagus	4.07e-05	0.00035	CbGpPWpGaD
Afatinib—LCK—Immune System—RELA—Barrett's esophagus	4.05e-05	0.000348	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—Barrett's esophagus	3.83e-05	0.000329	CbGpPWpGaD
Afatinib—EGFR—Disease—PTGS2—Barrett's esophagus	3.77e-05	0.000324	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	3.75e-05	0.000322	CbGpPWpGaD
Afatinib—LCK—Disease—PTGS2—Barrett's esophagus	3.64e-05	0.000313	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APC—Barrett's esophagus	3.48e-05	0.000299	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APC—Barrett's esophagus	3.35e-05	0.000288	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TP53—Barrett's esophagus	3.25e-05	0.00028	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TP53—Barrett's esophagus	3.2e-05	0.000275	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	2.95e-05	0.000254	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RELA—Barrett's esophagus	2.72e-05	0.000234	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	2.62e-05	0.000225	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—Barrett's esophagus	2.56e-05	0.00022	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	2.47e-05	0.000212	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TP53—Barrett's esophagus	2.35e-05	0.000202	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.03e-05	0.000174	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.6e-05	0.000137	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TP53—Barrett's esophagus	1.57e-05	0.000135	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	1.52e-05	0.00013	CbGpPWpGaD
